256 results on '"Chen, Ronald C"'
Search Results
2. Prostate Cancer
3. Kidney Cancers
4. A community engagement training program for basic and translational cancer researchers
5. Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men’s Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
6. Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups
7. Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
8. Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
9. Reirradiation of Utracentrally Located Thoracic Tumors Using a 10-Fraction Hypofractionated Stereotactic Body Radiation Therapy Course: A Detailed Dosimetric Analysis
10. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors
11. EGFR as a potent CAR T target in triple negative breast cancer brain metastases
12. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
13. TVL1-IMPT: Optimization of Peak-to-Valley Dose Ratio Via Joint Total-Variation and L1 Dose Regularization for Spatially Fractionated Pencil-Beam-Scanning Proton Therapy
14. Health-related quality of life (HRQOL) results from PRESTO (AFT-19), a phase 3 randomized trial of intensification of androgen blockade in patients with high-risk biochemically relapsed castration sensitive prostate cancer.
15. A phase 2 trial of ADT interruption in patients responding exceptionally to AR-pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM/Alliance A032101).
16. Differences in Rural Versus Urban Patients With Prostate Cancer in Diagnosis and Treatment: An Analysis of a Population-Based Cohort
17. PD13-06 IMPLEMENTATION OF PRACTICE-LEVEL INTERVENTIONS FOR LOW-RISK PROSTATE CANCER IN A COMMUNITY PRACTICE
18. Implementation of patient-reported outcome measures into health care for men with localized prostate cancer
19. Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men’s Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
20. Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance
21. Demystifying radiation oncology clinical trial concerns for protocol scientific review and institutional review board committee members
22. Evaluation of the Dose Delivery Consistency and Its Dependence on Imaging Modality and Deformable Image Registration Algorithm in Prostate Cancer Patients
23. Testing the efficacy of a couple-focused, tailored eHealth intervention for symptom self-management among men with prostate cancer and their partners: the study protocol
24. Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
25. Simultaneous dose and dose rate optimization via dose modifying factor modeling for FLASH effective dose.
26. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer
27. Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients
28. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
29. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
30. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
31. Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms
32. Mapping the Memorial Anxiety Scale for Prostate Cancer to the SF-6D
33. Demographic and Clinical Factors Associated With Health-Related Quality-of-Life Profiles Among Prostate Cancer Survivors.
34. Why is a small sample size not enough?
35. Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry
36. MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).
37. PSA flare in patients with metastatic castration-resistant prostate cancer undergoing 177 Lu-PSMA treatment.
38. An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals
39. The Challenges of Accrual and Retention During COVID-19 in a Randomized Controlled Trial Testing A Dyad-focused eHealth Intervention Running title: Challenges of Accrual and Retention (Preprint)
40. 2791: A novel proton GRID method via scissor beams with peak-valley-dose-ratio optimization.
41. Lattice position optimization for LATTICE therapy
42. 33 - Late toxicities management
43. Income level and treatment selection in prostate cancer: analysis of a North Carolina population-based cohort
44. MP22-10 IMPACT OF SMOKING ON LONGITUDINAL HEALTH RELATED QUALITY OF LIFE MEASURES AMONG BLADDER CANCER SURVIVORS
45. Supplementary Figures 1-2, Supplementary Tables 1-2 from Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture
46. A treatment plan optimization method with direct minimization of number of energy jumps for proton arc therapy
47. Fraction optimization for hybrid proton‐photon treatment planning
48. The effect of integrating knowledge‐based planning with multicriteria optimization in treatment planning for prostate SBRT
49. Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC).
50. Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.